Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/29/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/27/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/27/21 | Initial statement of beneficial ownership of securities |
|
2 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 |